Memphasys (ASX: MEM) is an Australian-based bio-separations company developing the Felix device – a unique device for quickly separating high quality sperm from a semen sample for use in human IVF procedures. Globally, human fertility rates are in decline and technologies such as IVF are increasing...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Address:
null
LOW
spending power
